Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services.

Monday, 4 April 2016

Biodetectors and Accessories Market Share And Trend Analysis From 2015 To 2022

Global biodetectors and accessories market is expected to reach USD 14.9 billion by 2022, according to a new study by Grand View Research, Inc.Increasing prevalence of airborne and contact diseases such as anthrax, coronavirus, and plague is a high impact rendering driver of biodetectors and accessories market.

According to the World Health Organization (WHO),plague is a severe air-borne disease with casefatality ratio of 30%-60% and there were 783 cases reported globally in 2013. Moreover, continuous deterioration of environmental conditions as a consequence of increasing pollution is anticipated to induce demand for biodetectors and accessories market.

Furthermore, the advent of technologically-advanced products such as microfluidics-based detectors, micro arrays, PCR, and electrochemiluminescence-based devices is anticipated to propel demand for biodetectors in a wide range of applications, thereby fueling growth of overall market over the forecast period. For instance, in November 2015, Smiths Detection launched TRACE-PRO, probe-based non-radioactive explosives detector.

This product exhibited enhanced speed and increased efficiency of the sample screening. The aforementioned factors are expected to serve as key contributing factors towards growth of biodetectors and accessories market over the forecast period.

In 2014, instruments dominated the product segment, accounting for a revenue share of over 35.0%, owing to its incorporation in a wide range of applications such as biohazard detection, pharmaceutical research, and forensic sciences

The clinical applications market held a substantial share constituting of over 44.0% of the overall revenue owing to rising incorporation of biodetector kits & reagents in DNA analysis, human cell identification, laboratory-based pathogen testing, and toxin detection and identification.

Point of care testing dominated the end-use segment as a consequence of rising penetration of these devices in medical analytics, toxicology, drug screening, and rapid diagnosis of heart diseases through detection of biomarkers. Other end-use segment inclusive of biodefense is anticipated to be the fastest growing market owing to rising R&D investments in chemical detection systems coupled with high threat of bioterrorism and disease outbreaks.

New product development in an attempt to cater to the changing consumer requirements, is a viable sustainability strategy adopted by these market participants. For instance, in November 2015, PositiveID Corporation developed “New Firefly Dx Prototype System” with enhanced PCR capabilities enabling the detection of multiple pathogens in lower quantities.